Enhancer reporter assay

MD Meijun Du
LT Lori Tillmans
JG Jianzhong Gao
PG Ping Gao
TY Tiezheng Yuan
RD Rachel L Dittmar
WS Wei Song
YY Yuehong Yang
NS Natasha Sahr
TW Tao Wang
GW Gong-Hong Wei
ST Stephen N. Thibodeau
LW Liang Wang
request Request a Protocol
ask Ask a question
Favorite

SNPs rs4631830 and rs13394027 were selected for enhancer reporter assay. The SNP-centered DNA fragment (~500 bp) was amplified from human genomic DNA and cloned into upstream of the SV40 promoter in the pGL3 promoter vector (Promega, Madison, WI). For allele-specific enhancer activity, site-directed mutagenesis (Stratagene, La Jolla, CA) was used to create allele-specific construct. The oligo sequences used in this mutagenesis were listed in Supplementary Table S6. In addition, the PSA (prostate-specific antigen) enhancer-containing fragment (~600 bp) was used as a positive control. Plasmid DNAs were prepared and purified using QIAprep Miniprep kit (Qiagen,Valencia,CA). For plasmid transfection on white 96-well tissue culture plates, 100 ul suspension (3 × 105 cells/ml) of LNCaP cells per well were applied to reverse transfection with luciferase reporter plasmids together with pGL75 using X-tremeGENE HP DNA Transfection Reagent (Roche Applied Science, Penzberg, Upper Bavaria, Germany) following the manufacturer’s instructions. 48 hours later, cells were analyzed for luciferase activities using Dual-Glo® Luciferase Assay System (Promega). All data came from five replicate wells.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A